feasibility of biomarker-driven strategy in high-risk lbcl: final results from nordic phase ii study
Published 1 year ago • 48 plays • Length 2:19Download video MP4
Download video MP3
Similar videos
-
1:12
using biomarkers and genomics to inform treatment strategy in all
-
1:38
feasibility study of computer vision for quantifying cardiac amyloid burden in biopsies
-
1:13
the current bsh guidelines for the diagnosis and evaluation of prognosis of myelofibrosis
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:20
ultra high-risk myeloma
-
11:32
biorisk management: introductory module
-
1:06:33
discovering biomarkers, predicting cardiovascular disease using novel nexus machine learning techs
-
1:12:23
biomarker discovery and machine learning in large... - zhaleh safikhani - tutorials - ismb/eccb 2019
-
4:31
labmt: impact of treatment prior to allogenic hct in mds
-
3:20
using biomarkers to guide secondary prevention in ischemic stroke
-
17:10
a process for finding and validating biotech startup ideas
-
5:18
upfront treatment in transplant candidates
-
0:56
biomarkers for risk assessment and early diagnosis of ad
-
1:33:24
new horizons for biomarker technologies
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
4:18
significance of cell polarity in the ageing of hematopoietic stem cells
-
5:07
daratumumab in the management of al amyloidosis
-
4:18
novel drugs in the r/r mm: imids
-
4:57
oncology biomarker development at genentech
-
1:53
the future of multiple myeloma treatment
-
0:52
tocilizumab for aa amyloidosis